MULTISSYSTEM INFLAMMATORY SYNDROME IN A POST-COVID PEDIATRIC PATIENT: CASE REPORT
DOI:
https://doi.org/10.47820/recima21.v6i1.7097Keywords:
Multisystem Inflammatory Syndrome. SARS-CoV-2. COVID-19. Kawasaki disease. Toxic Shock Syndrome.Abstract
Multisystem Inflammatory Syndrome in Children (MIS-C) is a severe post-infectious complication of COVID-19, characterized by hyperinflammation that mimics Kawasaki Disease and Toxic Shock Syndrome. Objective: To describe the clinical aspects and therapeutic management of a MIS-C case. Method: Case report of a patient treated at a teaching hospital in São Paulo, with data obtained from medical records. Case Description: A 10-year-old male patient was admitted with persistent fever, gastrointestinal symptoms, and hemodynamic instability. The investigation ruled out bacterial sepsis; laboratory tests showed elevated inflammatory markers and positive IgG serology for SARS-CoV-2 (with negative RT-PCR). Treatment was instituted with intravenous immunoglobulin (IVIG), corticosteroids, and intensive support. The patient progressed with significant clinical improvement and was discharged. Conclusion: MIS-C requires a high index of suspicion. Precise differentiation from other inflammatory syndromes and serological confirmation are crucial for assertive immunomodulatory treatment and a favorable prognosis.
Downloads
References
1 Son MBF, Friedman K. Coronavirus disease 2019 (COVID-19): Multisystem inflammatory syndrome in children (MIS-C) clinical features, evaluation, and diagnosis. 2020. [acesso em 21 de set 2020]. Disponível em: https://www.uptodate.com/contents/coronavirus-disease-2019-covid-19-multisystem-inflammatory-syndrome-in-children-mis-c-clinical-features-evaluation-and-diagnosis.
2 Rowley AH. Understanding SARS-CoV-2-related multisystem inflammatory syndrome in children. Nature Reviews Immunology; June 2020. [acesso em 21 set 2020];453–454. 2020. DOI: https://doi.org/10.1038/s41577-020-0367-5
3 Deville JG, Song E, Ouellette CP. Coronavirus disease 2019 (COVID-19): Clinical manifestations and diagnosis in children. 2020. [acesso em 22 out 2020]. Disponível em: https://www.uptodate.com/contents/coronavirus-disease2019covid19clinicalmanifestationsanddiagnosisinchildren?search=pims%20ts&source=search_result&selectedTitle=2~92&usage_type=default&display_rank=2
4 Lawrensia S, Henrina J, Wijaya E, Suciadi LP, Saboe A, Cool CJ. Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2: a New Challenge amid the Pandemic. 2077-2085. 2020 [acesso em 23 out 2020]. Disponível em: https://link.springer.com/article/10.1007/s42399-020-00602-8 DOI: https://doi.org/10.1007/s42399-020-00602-8
5 Sociedade Brasileira de Pediatria, Departamento Científico de Infectologia, de Reumatologia, de Cardiologia, de Terapia Intensiva e de Emergência. Notificação obrigatória no Ministério da Saúde dos casos de síndrome inflamatória multissistêmica pediátrica (SIM-P) potencialmente associada à COVID-19. 2020. [acesso em 15 set 2020]. Disponível em:
6 De Carvalho HT, Fioretto JR, Ribeiro CF, Laraia IO, Carpi MF. Diagnóstico e tratamento da síndrome do choque tóxico estreptocócico em unidade de terapia intensiva pediátrica: relato de caso. Rev Bras Ter Intensiva. 2019;31(4):586-591.
7 Fernandez-Sarmiento J, De Souza D, Jaborninsy R, et al. Paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): a narrative review and the viewpoint of the Latin American Society of Pediatric Intensive Care (SLACIP) Sepsis Committee. BMJ Paediatr Open. 2021;5(1). DOI: https://doi.org/10.1136/bmjpo-2020-000894
8 American Academy of Pediatrics. Staphylococcal infections. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, eds. Red Book: 2009 28th ed. Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics; 2006. p. 601-15.
9 American Academy of Pediatrics. Group A streptococcal infections. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS. (Eds). Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009. p. 616-28.
10 Alvim ALS, Volpato AT, Gomes EM, et al. Síndrome inflamatória multissistêmica em crianças e adolescentes com COVID-19: uma revisão de literatura. Journal of Infection Control. 2020;9(3).
11 Son MBF, Friedman K. COVID-19: Multisystem inflammatory syndrome in children (MIS-C) management and outcome. UpToDate, 2022 [acesso em 15 de setembro de 2022]. Disponível em:
12 Klok F, Kruip MJHA, Van Der Meerc NJM, Arbouse MS, Gommers D, Kant KM, et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res. 2020;191:148-150. DOI: https://doi.org/10.1016/j.thromres.2020.04.041
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2025 RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218
This work is licensed under a Creative Commons Attribution 4.0 International License.
Os direitos autorais dos artigos/resenhas/TCCs publicados pertecem à revista RECIMA21, e seguem o padrão Creative Commons (CC BY 4.0), permitindo a cópia ou reprodução, desde que cite a fonte e respeite os direitos dos autores e contenham menção aos mesmos nos créditos. Toda e qualquer obra publicada na revista, seu conteúdo é de responsabilidade dos autores, cabendo a RECIMA21 apenas ser o veículo de divulgação, seguindo os padrões nacionais e internacionais de publicação.
